NTLA logo
NTLA NASDAQ US

Intellia Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO May 2016
$13.13
▼ $-0.14 (-1.06%)
Vol 2.7M
4
Quality Score
fail
Mkt Cap
$1.0B
ROE
-57.2%
Margin
-774.9%
D/E
0.00
Beta
2.06
52W
$6–$28

Wall Street Consensus

30 analysts · Apr 2026
6
Strong Buy
11
Buy
11
Hold
2
Sell
0
Strong Sell
56.7%
Buy Rating

Price Chart

Similar Stocks

ZYME
Zymeworks Inc
$2.0B
ANAB
AnaptysBio Inc
$1.3B
RXRX
Recursion Pharmaceuticals Inc
$2.1B
NRIX
Nurix Therapeutics Inc
$1.9B
ARDX
Ardelyx Inc
$1.4B
VIR
Vir Biotechnology Inc
$838.9M
IOVA
Iovance Biotherapeutics Inc
$1.1B

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.97 $-0.83 +$0.14
Sep 2025 $-1.02 $-0.92 +$0.10
Jun 2025 $-1.04 $-0.98 +$0.06
Mar 2025 $-1.31 $-1.10 +$0.21

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -57.7% -57.7% -57.7% -57.7% -57.2% -57.2%
P/E (TTM) — — — — — —
Net Margin -710.8% -908.5% -908.5% -908.5% -774.9% -774.9%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 5.19 5.19 5.19 5.19 6.21 6.21

Key Ratios

ROA (TTM)
-44.6%
P/S (TTM)
18.10
P/B
1.4
EPS (TTM)
$-4.27
CF/Share
$-5.25
Rev Growth 3Y
+20.5%
52W High
$28.25
52W Low
$5.90
$5.90 52-Week Range $28.25

How does NTLA compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

NTLA AAPG ABEO ABOS ABP

NTLA valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
18.1
▲ 41% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.4
▼ 45% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

NTLA profitability vs Biotechnology peers

ROE
-57.2%
▲ 15% above peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
-774.9%
▼ 170% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-44.6%
▲ 5% above peers (-46.7%)
vs Peers
vs Industry
In line

NTLA financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
6.2
▲ 40% above peers (4.4)
vs Peers
vs Industry
Below avg
Beta
2.1
▲ 112% above peers (1.0)
vs Peers
vs Industry
More volatile

NTLA fundamentals radar

NTLA Peer median Industry

NTLA profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

NTLA vs peers: key metrics

Latest News

No related news yet